Total Payments
$8,408
2024 Payments
$915.85
Companies
46
Transactions
489
Medicare Patients
1,569
Medicare Billing
$157,504
Payment Breakdown by Category
Food & Beverage$8,381 (99.7%)
Education$27.08 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,381 | 486 | 99.7% |
| Education | $27.08 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,366 | 64 | $0 (2024) |
| Novo Nordisk Inc | $1,019 | 64 | $0 (2024) |
| ABBVIE INC. | $746.62 | 58 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $628.01 | 28 | $0 (2024) |
| Lilly USA, LLC | $587.36 | 42 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $429.61 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $422.53 | 19 | $0 (2023) |
| Merck Sharp & Dohme LLC | $331.00 | 26 | $0 (2024) |
| Amgen Inc. | $298.18 | 20 | $0 (2024) |
| Lundbeck LLC | $273.27 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $915.85 | 57 | Lilly USA, LLC ($160.03) |
| 2023 | $896.29 | 54 | AbbVie Inc. ($205.90) |
| 2022 | $995.23 | 57 | ABBVIE INC. ($159.58) |
| 2021 | $1,029 | 63 | AbbVie Inc. ($193.44) |
| 2020 | $1,091 | 63 | Novo Nordisk Inc ($195.93) |
| 2019 | $1,185 | 65 | Novo Nordisk Inc ($178.19) |
| 2018 | $1,075 | 55 | AstraZeneca Pharmaceuticals LP ($415.53) |
| 2017 | $1,221 | 75 | AstraZeneca Pharmaceuticals LP ($246.16) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Obesity | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: VACCINE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.07 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Obesity | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 396 | 602 | $136,157 | $44,196 |
| 2022 | 7 | 380 | 567 | $128,502 | $42,697 |
| 2021 | 8 | 415 | 597 | $115,927 | $38,571 |
| 2020 | 7 | 378 | 531 | $115,290 | $32,040 |
Total Patients
1,569
Total Services
2,297
Medicare Billing
$157,504
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 259 | $69,770 | $21,248 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 100 | 100 | $34,200 | $12,891 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 131 | $23,973 | $7,423 | 31.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 14 | $2,562 | $1,018 | 39.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 15 | 18 | $1,980 | $697.80 | 35.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,320 | $546.84 | 41.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $870.00 | $151.71 | 17.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 15 | $1,140 | $136.68 | 12.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 38 | $342.00 | $83.60 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 251 | $67,770 | $21,587 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 85 | 85 | $29,070 | $11,161 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 115 | $21,045 | $6,872 | 32.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 27 | 36 | $6,588 | $2,046 | 31.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 22 | 25 | $2,750 | $842.82 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $928.00 | $104.05 | 11.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 29 | 39 | $351.00 | $84.64 | 24.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 111 | 207 | $55,890 | $17,756 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 171 | $31,293 | $10,222 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 53 | 53 | $18,126 | $7,032 | 38.8% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 49 | 49 | $4,732 | $1,849 | 39.1% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 51 | 51 | $3,418 | $1,288 | 37.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 17 | $1,292 | $191.02 | 14.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 15 | $870.00 | $157.69 | 18.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 26 | 34 | $306.00 | $74.25 | 24.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 178 | $48,060 | $12,200 | 25.4% |
About Dr. Natashia Conley, MD
Dr. Natashia Conley, MD is a Internal Medicine healthcare provider based in Peachtree City, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659347581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Natashia Conley, MD has received a total of $8,408 in payments from pharmaceutical and medical device companies, with $915.85 received in 2024. These payments were reported across 489 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,381).
As a Medicare-enrolled provider, Conley has provided services to 1,569 Medicare beneficiaries, totaling 2,297 services with total Medicare billing of $157,504. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Family Medicine
- Location Peachtree City, GA
- Active Since 02/28/2006
- Last Updated 11/02/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659347581
Products in Payments
- FARXIGA (Drug) $1,172
- REXULTI (Drug) $685.42
- Ozempic (Drug) $478.65
- JARDIANCE (Drug) $411.14
- VRAYLAR (Drug) $400.20
- TRULICITY (Drug) $358.79
- JANUVIA (Drug) $257.34
- UBRELVY (Drug) $238.43
- MYRBETRIQ (Drug) $180.57
- Natesto (Drug) $176.93
- Saxenda (Drug) $172.39
- Victoza (Drug) $161.74
- SOLIQUA (Drug) $155.82
- TOUJEO (Drug) $152.60
- XIFAXAN (Drug) $142.50
- BYDUREON (Drug) $134.05
- NAFTIN (Drug) $132.38
- Aimovig (Biological) $131.84
- NAMZARIC (Drug) $126.32
- MOUNJARO (Drug) $125.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Peachtree City
Amanda Worme, Md, MD
Internal Medicine — Payments: $3,023
Internal Medicine $3,023
Dr. Zia Khan, Md, MD
Internal Medicine — Payments: $1,768
Internal Medicine $1,768
Dr. Michael Obenshain, Md, MD
Internal Medicine — Payments: $237.73
Internal Medicine $237.73
Dr. Unnisa Faiyaz, M.d, M.D
Internal Medicine
Internal Medicine
Dr. Kimberly Wollenhaupt, Md, MD
Internal Medicine
Internal Medicine